Oramed Pharmaceuticals (ORMP) Property, Plant & Equipment (Net) (2011 - 2026)

Oramed Pharmaceuticals (ORMP) Property, Plant & Equipment (Net) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 67,042.03 Bn 67,041.74 Bn - 642,333.36
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn - 5.32 Mn
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 472.89 Bn 468.10 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 122.12 Bn 114.87 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 70.04 Bn 61.29 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.68 Bn 62.68 Bn - -
8 Argenx Se 55.90 Bn 50.72 Bn 1.41 Bn 1.96 Bn
9 Alnylam Pharmaceuticals 37.47 Bn 34.46 Bn 959.66 Mn 518.26 Mn
10 Oramed Pharmaceuticals 168.80 Mn 168.80 Mn - 561,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 561,000.00
Mar 31, 2026 561,000.00
Dec 31, 2025 586,000.00
Dec 31, 2025 586,000.00
Sep 30, 2025 614,000.00
Sep 30, 2025 614,000.00
Jun 30, 2025 645,000.00
Jun 30, 2025 645,000.00
Mar 31, 2025 671,000.00
Mar 31, 2025 671,000.00
Dec 31, 2024 698,000.00
Dec 31, 2024 698,000.00
Sep 30, 2024 718,000.00
Sep 30, 2024 718,000.00
Jun 30, 2024 765,000.00
Jun 30, 2024 765,000.00
Mar 31, 2024 819,000.00
Mar 31, 2024 819,000.00
Dec 31, 2023 873,000.00
Dec 31, 2023 873,000.00